Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2014
Emily Dykhuizen, Ph.D.
The Role of the Bromodomains of PBRM1, a Tumor Suppressive Subunit of...
Read More
2014
Angela Fleischman, M.D., Ph.D.
Pathogenesis of Calreticulin-Mutated Myeloproliferative Neoplasm
Read More
2014
Wenjun Guo, Ph.D.
Role of Novel Breast Cancer Mutations in Cell Fate dysregulation and Oncogenesis
Read More
2014
Mohit Jain, M.D., Ph.D.
Systematic Discovery of Metabolic Vulnerabilities in Cancer
Read More
2014
Randall J. Kimple,. M.D., Ph.D.
Unmasking the Role of HPV in Modulating Tumor Behavior and Therapy Response
Read More
2014
Andrew A. Lane, M.D., Ph.D.
Defining the Contribution of Chromosome X to Gender-specific Cancer Presdisposition
Read More
2014
Megan McNerney, M.D., Ph.D.
Transcriptional Misregulation in High-risk Myeloid Neoplasms
Read More
2014
Chad V. Pecot, M.D.
Tumor Angiogenesis Regulation by the miR-200 Family
Read More
2014
Karen Sandell Sfanos, Ph.D.
Alterations in Urinary Tract Microbiome as a Risk Factor for Prostate Cancer
Read More
2014
Agnel Sfeir, Ph.D.
Targeting Polymerase Theta Mediated Double-Strand Break (DSB)
Read More
2014
Ruoning Wang, Ph.D.
Metabolic Reprogramming and modulation of Adaptive Immunity in Tumour Microenvironment
Read More
2014
John S. Welch, M.D., Ph.D.
STAG2 Mutations in Leukemia, Hematopoietic Differentiation and Chromatin Structure
Read More
2014
Omer Yilmaz, M.D., Ph.D.
The Mammalian Stem Cell Niche in Cancer
Read More
2014
Weizhou Zhang, Ph.D.
Metformin and Nlrc4-inflammasome in obesity-associated cancer progression
Read More
2014
Jessie Villanueva, Ph.D.
Interrogating the Role of S6K as a Molecular Target in Melanoma
Read More
2014
Judy Villablanca, M.D.
New approaches to neuroblastoma Therapy (NANT) Consortium
Read More